- Home
- SRZN vs DBL Comparison
SRZN vs DBL Comparison
Compare SRZN & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRZN | DBL |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 268.9M |
| IPO Year | 2020 | 2011 |
Fundamental Metrics
Financial Performance| Metric | SRZN | DBL |
|---|---|---|
| Price | $25.83 | $13.69 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $48.40 | N/A |
| AVG Volume (30 Days) | ★ 942.2K | 154.2K |
| Earning Date | 11-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,477,000.00 | N/A |
| Revenue This Year | $208.89 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $11.39 | $12.94 |
| 52 Week High | $37.83 | $15.70 |
Technical Indicators
Market Signals| Indicator | SRZN | DBL |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 55.89 |
| Support Level | $23.31 | $12.94 |
| Resistance Level | $28.78 | $14.45 |
| Average True Range (ATR) | 2.74 | 0.21 |
| MACD | -0.34 | 0.06 |
| Stochastic Oscillator | 43.37 | 97.62 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest
Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.